Riskpilot← Back to searchSign inGet full accessPtarmigan Labs AB
ABActiveOrg 5591396162Strandpromenaden 53Computer programming activities · NACE 6210Est. 20170 employees
Revenue 2025
SEK 1,7M
+300% vs 2024
EBITDA margin
40.1%
+308% vs 2024
Equity ratio
43.7%
Financial strength
Net profit 2025
SEK 589K
+221% vs 2024
| Revenue | SEK 1,7M | +300% |
| EBITDA | SEK 684K | +308% |
| Net profit | SEK 589K | +221% |
| Total assets | SEK 4,3M | +11% |
| Equity | SEK 1,9M | +26% |
| Employees | 0 | — |
Legal name
Ptarmigan Labs AB
Org number
5591396162
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
14 december 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom IT (utveckling av mjukvara, elektronik, inbyggda system samt utbildning inom dessa områden), äga och förvalta värdepapper, samt verksamhet förenlig med tidigare nämnda områden.
Address
Strandpromenaden 53
Email
goran.sander@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 250 | 1 575 | 1 360 | 426 | 1 704 |
| Staff expenses | — | −875 | −865 | −666 | — |
| EBITDA | 277 | 639 | 387 | −329 | 684 |
| Depreciation & amort. | −5 | −5 | −5 | −4 | −14 |
| EBIT | 272 | 634 | 383 | −333 | 670 |
| Net financials | 267 | 0 | 2 | −153 | −56 |
| Profit before tax | −45 | 634 | 385 | −485 | 614 |
| Tax | −51 | −131 | −81 | — | −25 |
| Net profit | −96 | 503 | 304 | −485 | 589 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 529 | 3 995 | 4 191 | 3 909 | 4 339 |
| Equity | 1 386 | 1 889 | 2 093 | 1 508 | 1 897 |
| Long-term debt | 2 048 | 2 048 | 2 048 | 2 204 | 2 191 |
| Short-term debt | 95 | 57 | 50 | 197 | 252 |
| Total debt | 2 143 | 2 105 | 2 098 | 2 401 | 2 443 |
EBITDA margin
40.1%
This company
15.8%
Market median
+154% vs market
20212025
Equity ratio
43.7%
This company
38.2%
Market median
+14% vs market
20212025
Return on equity
31.0%
This company
18.4%
Market median
+68% vs market
20212025
Net profit margin
34.6%
This company
8.1%
Market median
+327% vs market
20212025
Asset turnover
0.39×
This company
1.12×
Market median
-65% vs market
20212025
Debt / equity
1.29×
This company
0.62×
Market median
-108% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ptarmigan Labs AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Göran Sander | Board of Directors | 0 companies |
| Anna Margareta Undén | Deputy Board Member | 0 companies |